What is the total value of India's pharmaceutical export to Brazil?

India exported pharmaceuticals worth $200.0M to Brazil across 1,452 verified shipments.

Which companies in Brazil import pharmaceuticals from India?

1. NOVO NORDISK INDIA PRIVATE LIMITED — $161.5M. 2. INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED — $13.5M. 3. ZOETIS INDIA LIMITED — $8.5M. 72 buyers total.

What pharmaceutical products does India export most to Brazil?

1. Insulin ($161.5M, 80.7%); 2. Serum ($15.2M, 7.6%); 3. Vaccine ($8.5M, 4.2%); 4. Dexamethasone ($4.0M, 2.0%); 5. Moxifloxacin ($4.0M, 2.0%)

Why does Brazil import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $200.0M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Brazil?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Brazil pharmaceutical trade?

$137.7K per consignment across 1,452 shipments.

How many Indian pharmaceutical companies export to Brazil?

155 Indian companies. Largest: M/S. NOVO NORDISK A/S with $79.0M.

How can I find verified Indian pharmaceutical suppliers for Brazil?

TransData Nexus covers 155 active exporters with shipment history and trade values at transdatanexus.com.

Brazil to India Pharmaceutical Import (2026) — $200.0M, 155 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to Brazil?

1. M/S. NOVO NORDISK A/S — $79.0M. 2. NOVO NORDISK A/S — $35.0M. 3. M S NOVO NORDISK A S — $16.0M. Total: 155 suppliers.

Brazil to India Pharmaceutical Import (2026) — $200.0M, 155 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Brazil to India

#	Formulation	Value	Share
1	Insulin	$161.5M	80.7%
2	Serum	$15.2M	7.6%
3	Vaccine	$8.5M	4.2%
4	Dexamethasone	$4.0M	2.0%
5	Moxifloxacin	$4.0M	2.0%
6	Empagliflozin	$2.3M	1.2%
7	Semaglutide	$720.4K	0.4%
8	Sodium	$596.7K	0.3%
9	Heparin	$457.2K	0.2%
10	Amphotericin	$271.0K	0.1%
11	Lenalidomide	$249.7K	0.1%
12	Olaparib	$220.2K	0.1%
13	Cabozantinib	$207.9K	0.1%
14	Nilotinib	$165.4K	0.1%
15	Ibrutinib	$154.7K	0.1%

India imports 20+ pharmaceutical formulations from Brazil with a combined trade value of $200.0M. Key products include Insulin ($161.5M), Serum ($15.2M), Vaccine ($8.5M), Dexamethasone ($4.0M), Moxifloxacin ($4.0M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,452 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Brazil to India Trade Routes

1Insulin$161.5M

2Serum$15.2M

3Vaccine$8.5M

4Dexamethasone$4.0M

5Moxifloxacin$4.0M

Top Brazil Suppliers to India

1M/s. Novo Nordisk A/s

$79.0M

2Novo Nordisk A/s

$35.0M

3M S Novo Nordisk A S

$16.0M

4Life Technologies Limited....

$12.0M

5Novo Nordisk A S

$10.5M

Trade Statistics

Total Value$200.0M

Shipments1,452

Indian Exporters155

Brazil Buyers72

Avg Shipment$138K

Products102

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Brazil Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Brazil and India has experienced significant growth from 2022 to 2026. In 2022, the total import value was approximately $50 million USD, with 300 shipments from 50 Brazilian suppliers to 30 Indian buyers. By 2026, these figures escalated to a total import value of $200 million USD, encompassing 1,452 shipments from 155 Brazilian suppliers to 72 Indian buyers. This fourfold increase underscores the strengthening bilateral trade relations and India's growing reliance on Brazilian pharmaceutical products.

2Brazil's Role in India's Pharma Imports

Brazil's contribution to India's pharmaceutical imports has become increasingly significant. In 2026, Brazil accounted for approximately 5% of India's total pharmaceutical imports, positioning it among the top ten suppliers. The primary categories imported from Brazil include insulin, vaccines, and other essential medications, reflecting Brazil's capacity to meet India's demand for both generic and specialized pharmaceutical products.

3Recent Developments

Between 2024 and 2026, several key developments have influenced the pharmaceutical trade between Brazil and India. In April 2024, the Central Drugs Standard Control Organisation (CDSCO) introduced streamlined procedures for the registration of foreign pharmaceutical products, facilitating easier market entry for Brazilian companies. Additionally, in January 2025, India and Brazil signed a bilateral trade agreement aimed at enhancing cooperation in the pharmaceutical sector, including joint ventures and technology sharing. These initiatives have contributed to the expansion of the trade corridor.

Brazil Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

Brazilian pharmaceutical companies seeking to import products into India must navigate the CDSCO registration process. The initial step involves appointing an Authorized Indian Representative (AIR), as foreign manufacturers cannot apply directly. The AIR submits an Integrated Registration Form (IRF) through the CDSCO's SUGAM portal, providing details about the applicant, manufacturing site, and product information. Essential documents include a Power of Attorney, Site Master File, and a Free Sale Certificate. The CDSCO reviews the application, which may involve site inspections, and issues a Registration Certificate upon approval. The entire process typically spans several months, depending on the complexity of the application.

2GMP & Manufacturing Standards

India mandates that foreign manufacturing sites adhere to Good Manufacturing Practice (GMP) standards as outlined by the World Health Organization (WHO). Brazilian manufacturers must ensure their facilities comply with these standards, which encompass quality management systems, personnel qualifications, and production controls. The CDSCO conducts inspections to verify compliance, and a WHO prequalification is often required for certain products. Non-compliance can result in delays or rejections of import applications.

3Import Documentation

To import pharmaceutical products into India, Brazilian companies must secure an Import License (Form 10) from the CDSCO. This license authorizes the importation of specific products and is valid for a defined period. Additional documentation includes a Registration Certificate, No Objection Certificate (NOC) for dual-use goods, and a Test License for products intended for clinical trials or testing. Customs procedures require detailed product information, including labeling and packaging compliance with Indian regulations.

TransData Nexus Research · Brazil regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Brazil identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,452 verified shipments from 155 Indian exporters to 72 Brazil buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

155 Exporters

72 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Brazil to India Pharmaceutical Import

Top Pharmaceutical Formulations — Brazil to India

Top Pharmaceutical Products — Brazil to India Trade Routes

Top Brazil Suppliers to India

Trade Statistics

Other Import Origins

India–Brazil Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Brazil's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Brazil

Product Routes

Full Dataset Access

Brazil Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Brazil

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Brazil

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Brazil Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

Market Opportunity Assessment — Brazil for Indian Pharma

1India's Import Dependency

2Brazil Companies in India

3Outlook & Self-Reliance

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Brazil

1Competing Import Origins

FAQ — India to Brazil Pharmaceutical Trade